Discussion on “Predictively consistent prior effective sample sizes,” by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan

Authors

Atanu Biswas, Indian Statistical Institute, Kolkata
Jean François Angers, University of Montreal

Article Type

Research Article

Publication Title

Biometrics

Abstract

We extend the approach of finding effective sample size for a typical phase II clinical trial having efficacy and toxicity as two components of the response vector. The case of binary efficacy and binary toxicity is illustrated under Dirichlet and multivariate T priors.

First Page

591

Last Page

594

DOI

10.1111/biom.13247

Publication Date

6-1-2020

Recommended Citation

Biswas, Atanu and Angers, Jean François, "Discussion on “Predictively consistent prior effective sample sizes,” by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan" (2020). Journal Articles. 276.
https://digitalcommons.isical.ac.in/journal-articles/276